The limitations of general-purpose AI in an emotional support context aren’t what it says. They’re about what it can’t detect, including the markers of acute distress that a purpose-built system is specifically architected to recognize. The post When There’s No Appointment Available, Patients Are Opening ChatGPT appeared first on MedCity News.
This issue brief provides background on the GENEROUS model, examines the factors that will contribute to the model’s overall impact on Medicaid drug costs, and illustrates how savings will depend on model details that are confidential or uncertain at this time.
Is $50 billion over five years enough to end the rural healthcare crisis or even offset the federal spending cuts? No – but it’s what states have to work with. And the pressure is on them to maximize the impact of their RHTP grants. Here’s how they can do it. The post How States Can…
When Gavin Newsom ran for California governor in 2018, his support for a state-run single-payer healthcare system was considered a risky move and earned him hefty labor endorsements. Today, leading Democrats in the wide-open race to succeed Newsom have embraced single-payer as a political necessity, an answer to voters fed up with rising premiums and…
Privacy between doctors and patients is protected by law. But the Trump administration is, in effect, trying to peek into the exam room. The Office of Personnel Management is seeking unredacted federal worker health data from insurers. The unusual request, which would give the government detailed personal and health information, alarmed health policy and legal…
A new report from Gibbins Advisors showed that healthcare bankruptcy filings rose 33% in the first quarter of 2026, driven mostly by outpatient and senior care providers. At the same time, hospital M&A activity rebounded to its strongest first quarter since early 2020. The post Healthcare Bankruptcies Rise in Q1: 6 Things to Know appeared…
Angelini Pharma’s acquisition of Catalyst Pharmaceuticals is part of a transformation strategy focused on neurological medicines. Catalyst’s top product is Firdapse, the first FDA-approved drug for a particular rare neuromuscular disorder. The post Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy appeared first on MedCity News.
Executive recruiting firm execs say the number of chief AI officers has more than quadrupled over the last few years
Patient observation is often misunderstood as simply “watching” a patient, yet its impact extends across patient safety, workforce stability, and clinical flow. In today’s care environments, observation requires trained awareness, consistent documentation, and recognition of subtle changes before escalation occurs. Myth vs. Fact explores common assumptions about patient observation programs and examines how structured approaches translate into real-world safety, workforce…
As people become richer, they generally spend more money on health. However, as countries become richer, do they spend more or less (relative to their GDP per capita) on health care innovation? A paper by Yu et al. (2026) looks at trends in willingness to pay thresholds between the US and countries in the most-favored…